Twist Bioscience Corporation

Twist Bioscience Corporation (TWST) Stock Overview

Explore Twist Bioscience Corporation’s financial performance, market position, analyst ratings, and future outlook.

TWSTNASDAQ
HealthcareMedical - Diagnostics & Research
$91.23
$1.38(1.49%)
U.S. Market opens in 17h 19m

Twist Bioscience Corporation (TWST)

Meyka AI Score

Z

Key Financials

Market Cap5.7B
P/E Ratio-69.30
EPS (TTM)$-2.13
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$81.85
3 Months$108.06
1 Year Target$58.01

TWST Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Twist Bioscience Corporation (TWST) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.73, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $58.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -69.30 and a market capitalization of 5.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.09%
5-Day Change
-1.21%
1-Month Change
14.63%
3-Month Change
60.73%
6-Month Change
124.40%
Year-to-Date (YTD) Change
191.96%
1-Year Change
154.63%
3-Year Change
283.16%
5-Year Change
-17.99%
All-Time (Max) Change
561.50%

Contact Information

800 719 0671
681 Gateway Boulevard, South San Francisco, CA, 94080

Company Facts

9,230 Employees
IPO DateOct 31, 2018
CountryUS
Actively Trading

Frequently Asked Questions